tiprankstipranks
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
Holding IKT?
Track your performance easily

Inhibikase Therapeutics (IKT) Similar Stocks

140 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Inhibikase Therapeutics
$157.23M
-0.86
168.97%
3 Buy
0 Hold
0 Sell
Strong Buy
Abeona Therapeutics
$258.22M
-2.20
37.82%
1 Buy
0 Hold
0 Sell
Moderate Buy
Adaptimmune Therapeutics
$178.25M
-3.24
49.89%
3 Buy
2 Hold
0 Sell
Moderate Buy
Actinium Pharmaceuticals
$45.23M
-1.04
-67.49%
3 Buy
0 Hold
0 Sell
Strong Buy
Cellectar Biosciences
$64.79M
-0.84
-25.24%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
IKT
Inhibikase Therapeutics
2.34
1.45
162.92%
ABEO
Abeona Therapeutics
5.94
1.13
23.49%
ADAP
Adaptimmune Therapeutics
0.70
0.22
45.83%
ATNM
Actinium Pharmaceuticals
1.45
-2.82
-66.04%
CLRB
Cellectar Biosciences
1.57
-0.57
-26.64%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis